Article Details
Retrieved on: 2019-10-31 20:33:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div><b>Kohlberg Kravis Roberts</b> & Co. L.P. acquired a new position in shares of BridgeBio Pharma during the 2nd quarter worth approximately $995,211,000.</div>
Article found on:
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here